These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19290795)

  • 1. CYP3A5 and ABCB1 genes and hypertension.
    Bochud M; Bovet P; Burnier M; Eap CB
    Pharmacogenomics; 2009 Mar; 10(3):477-87. PubMed ID: 19290795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
    Eap CB; Bochud M; Elston RC; Bovet P; Maillard MP; Nussberger J; Schild L; Shamlaye C; Burnier M
    Hypertension; 2007 May; 49(5):1007-14. PubMed ID: 17372036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
    Santoro A; Felipe CR; Tedesco-Silva H; Medina-Pestana JO; Struchiner CJ; Ojopi EB; Suarez-Kurtz G
    Pharmacogenomics; 2011 Sep; 12(9):1293-303. PubMed ID: 21806386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.
    Ferraresso M; Turolo S; Ghio L; Tirelli AS; Belingheri M; Villa R; Groppali E; Edefonti A
    Clin Exp Hypertens; 2011; 33(6):359-65. PubMed ID: 21851254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men.
    Zhang L; Miyaki K; Wang W; Muramatsu M
    J Hum Hypertens; 2010 May; 24(5):345-50. PubMed ID: 19812606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.
    Jordán de Luna C; Herrero Cervera MJ; Sánchez Lázaro I; Almenar Bonet L; Poveda Andrés JL; Aliño Pellicer SF
    Transplant Proc; 2011; 43(6):2241-3. PubMed ID: 21839244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.
    Glowacki F; Lionet A; Buob D; Labalette M; Allorge D; Provôt F; Hazzan M; Noël C; Broly F; Cauffiez C
    Nephrol Dial Transplant; 2011 Sep; 26(9):3046-50. PubMed ID: 21677300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients.
    Torio A; Auyanet I; Montes-Ares O; Guerra RM; Fernandez EJ; Perez MA; Ramirez A; Checa MD
    Transplant Proc; 2012 Nov; 44(9):2596-8. PubMed ID: 23146466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects.
    Hu M; Yang YL; Fok BS; Chan SW; Chu TT; Poon EW; Yin OQ; Lee VH; Tomlinson B
    Drug Metabol Drug Interact; 2012 Jan; 27(1):33-9. PubMed ID: 22718623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-environment interactions of selected pharmacogenes in arterial hypertension.
    Bochud M; Guessous I
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):677-86. PubMed ID: 23234325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of everolimus in cardiac recipients: comedications, ABCB1, and CYP3A5 polymorphisms.
    Lemaitre F; Bezian E; Goldwirt L; Fernandez C; Farinotti R; Varnous S; Urien S; Antignac M
    Ther Drug Monit; 2012 Dec; 34(6):686-94. PubMed ID: 23131698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
    Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A5 polymorphism, amlodipine and hypertension.
    Zhang YP; Zuo XC; Huang ZJ; Cai JJ; Wen J; Duan DD; Yuan H
    J Hum Hypertens; 2014 Mar; 28(3):145-9. PubMed ID: 23863802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
    Bosch TM; Huitema AD; Doodeman VD; Jansen R; Witteveen E; Smit WM; Jansen RL; van Herpen CM; Soesan M; Beijnen JH; Schellens JH
    Clin Cancer Res; 2006 Oct; 12(19):5786-93. PubMed ID: 17020985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy.
    Coto E; Tavira B; Marín R; Ortega F; López-Larrea C; Ruiz-Ortega M; Ortiz A; Díaz M; Corao AI; Alonso B; Alvarez V
    Biochem Biophys Res Commun; 2010 Jul; 397(3):576-9. PubMed ID: 20617557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
    Wei-lin W; Jing J; Shu-sen Z; Li-hua W; Ting-bo L; Song-feng Y; Sheng Y
    Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the CYP3A5 polymorphism (6986G>A) with blood pressure and hypertension.
    Xi B; Wang C; Liu L; Zeng T; Liang Y; Li J; Mi J
    Hypertens Res; 2011 Nov; 34(11):1216-20. PubMed ID: 21814220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CYP3A5 and MDR1 genetic polymorphisms on urinary 6 beta-hydroxycortisol/cortisol ratio after grapefruit juice intake in healthy Chinese.
    Li D; Abudula A; Abulahake M; Zhu AP; Lou YQ; Zhang GL
    J Clin Pharmacol; 2010 Jul; 50(7):775-84. PubMed ID: 20160155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population.
    Fisher DL; Plange-Rhule J; Moreton M; Eastwood JB; Kerry SM; Micah F; Johnston A; Cappuccio FP; MacPhee IA
    J Hum Hypertens; 2016 Dec; 30(12):778-782. PubMed ID: 27334520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous detection of CYP3A5 and MDR1 polymorphisms based on the SNaPshot assay.
    Li L; Li CJ; Zhang YJ; Zheng L; Jiang HX; Si-Tu B
    Clin Biochem; 2011 Apr; 44(5-6):418-22. PubMed ID: 21237140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.